Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Cells”

4,503 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,503 results

Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Large-scale testing (Phase 3)Study completedNCT01078454
What this trial is testing

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Looking for participantsNCT06920251
What this trial is testing

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Early research (Phase 1)Study completedNCT04813653
What this trial is testing

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Tel-Aviv Sourasky Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Study completedNCT00743288
What this trial is testing

Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma

Who this might be right for
Multiple Myeloma
Oncotherapeutics 40
Large-scale testing (Phase 3)Study completedNCT01208766
What this trial is testing

Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 1,503
Not applicableStudy completedNCT02556905
What this trial is testing

Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea

Who this might be right for
Multiple Myeloma
Celgene 624
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430894
What this trial is testing

KRDI in Transplant-Eligible MM

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02078102
What this trial is testing

A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin's Lymphoma
Sherif S. Farag 38
Not applicableLooking for participantsNCT06280924
What this trial is testing

Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple MyelomaExercisePrehabilitation
University of Alberta 30
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Early research (Phase 1)Study completedNCT01503242
What this trial is testing

90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 15
Large-scale testing (Phase 3)Active Not RecruitingNCT06868654
What this trial is testing

China Subpopulation: Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 72
Testing effectiveness (Phase 2)Study completedNCT00003954
What this trial is testing

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 40
Not applicableStudy completedNCT02921802
What this trial is testing

Special Use Results Surveillance of Revlimid 5mg Capsules

Who this might be right for
Multiple MyelomaMyelodysplastic Syndromes
Celgene 4,626
Testing effectiveness (Phase 2)Looking for participantsNCT07081646
What this trial is testing

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Who this might be right for
Relapsed AL AmyloidosisRefractory AL AmyloidosisLight Chain Amyloidosis+1 more
Alexion Pharmaceuticals, Inc. 91
Early research (Phase 1)Study completedNCT00006042
What this trial is testing

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Load More Results